Predicting Future Price Moves In ZyVersa Therapeutics Inc (ZVSA)

ZyVersa Therapeutics Inc (NASDAQ:ZVSA) does about 213.20K shares in volume on a normal day but saw 3187627 shares change hands in the recent trading day. The company now has a market cap of 3.94M USD. Its current market price is $4.75, marking an increase of 28.03% compared to the previous close of $3.71. The 52 week high reached by this stock is $94.50 whilst the lowest price level in 52 weeks is $3.41.

ZyVersa Therapeutics Inc (ZVSA) has a 20-day trading average at $4.23 and the current price is -94.97% off the 52-week high compared with 39.29% distance from its 52-week low. The 50-day simple moving average of the closing price is $4.68 and its 200-day simple moving average is $14.57. If we look at the stock’s price movements over the week, volatility stands at 12.66%, which decreases to 10.07% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 57.28 to suggest the stock is neutral.

The consensus objective for the share price is $20.00, suggesting that the stock has a potential upside of 76.25% over the period.

ZyVersa Therapeutics Inc (ZVSA) stock is up 31.49% over the week and -0.00% over the past month. Its price is -47.22% year-to-date and -94.78% over the past year.

The stock last released its quarterly earnings report for quarter ended 3/31/2024, with the company’s earnings per share (EPS) of -31.5 above consensus estimates by 24.5. The company’s next earnings report forecasts estimating quarterly EPS at -3.75 and -15.05 for whole year.

To reach the target analysts have set, the stock logically needs to grow 76.25 percent from here.

Outstanding shares total 0.83M with insiders holding 0.75% of the shares and institutional holders owning 1.37% of the company’s common stock. The company has a return on investment of -940.28% and return on equity of -180.17%. The beta has a value of 0.66. Price to book ratio is 0.35.